PATRICIA KIRBY: Open Payments
NPI 1215003207 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 8 payments from 4 companies in 2025. Trend: 2023 $1,824 · 2024 $833 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $117 |
| ABBVIE INC. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, TRINTELLIX.
Industry payments across AZ — which companies pay providers there.
